Brief: Geneuro and Alphabet's Verily Collaborate To Advance Long-Covid Research
Oct 19 (Reuters) - Geneuro SA GNRO.PA :
* GENEURO AND VERILY COLLABORATE TO ADVANCE LONG-COVID
RESEARCH
* COLLABORATION TO INVESTIGATE BIOMARKERS RELATED TO
ACTIVATION OF
PROINFLAMMATORY HERV-W ENVELOPE PROTEIN (W-ENV) IN SARS-COV-2
INFECTION
Source text for Eikon: ID:nBwc9JJyda
Further company coverage: GNRO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement